Fig. 1From: Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in ratsThe activity of RA-3 on FBG after the 28 days treatment of the type 2 diabetic animals. Values are expressed as the mean ± SEM (n = 5). ***p ≤ 0.001, vs. non-diabetic control. D diabeticBack to article page